NASDAQ:AMIX Autonomix Medical (AMIX) Stock Price, News & Analysis $1.02 +0.01 (+0.99%) Closing price 08/25/2025 04:00 PM EasternExtended Trading$1.02 0.00 (0.00%) As of 08/25/2025 07:23 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesOwnershipSEC FilingsShort InterestTrendsBuy This Stock About Autonomix Medical Stock (NASDAQ:AMIX) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get Autonomix Medical alerts:Sign Up Key Stats Today's Range$0.99▼$1.0450-Day Range$1.01▼$2.0152-Week Range$0.96▼$21.49Volume200,397 shsAverage Volume323,843 shsMarket Capitalization$5.25 millionP/E RatioN/ADividend YieldN/APrice Target$16.50Consensus RatingBuy Company Overview Autonomix Medical, Inc., a development stage medical device development company, focuses on advancing technologies for sensing and treating disorders relating to the peripheral nervous system. Its technology platform includes a catheter-based microchip-enabled sensing array to detect and differentiate peripheral neural signals. The company was incorporated in 2014 and is based in The Woodlands, Texas. Read More Autonomix Medical Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks56th Percentile Overall ScoreAMIX MarketRank™: Autonomix Medical scored higher than 56% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion3.5 / 5Analyst RatingBuy Consensus RatingAutonomix Medical has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 2 buy ratings, no hold ratings, and no sell ratings.Amount of Analyst CoverageAutonomix Medical has received no research coverage in the past 90 days.Read more about Autonomix Medical's stock forecast and price target. Earnings and Valuation1.3 / 5Proj. Earnings GrowthGrowing Earnings GrowthEarnings for Autonomix Medical are expected to grow in the coming year, from ($10.00) to ($5.22) per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Autonomix Medical is -0.18, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Autonomix Medical is -0.18, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioAutonomix Medical has a P/B Ratio of 0.31. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.Read more about Autonomix Medical's valuation and earnings. Short Interest2.0 / 5Short Interest LevelBearish Percentage of Shares Shorted10.71% of the float of Autonomix Medical has been sold short.Short Interest Ratio / Days to CoverAutonomix Medical has a short interest ratio ("days to cover") of 0.3, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Autonomix Medical has recently increased by 126.22%, indicating that investor sentiment is decreasing significantly. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldAutonomix Medical does not currently pay a dividend.Dividend GrowthAutonomix Medical does not have a long track record of dividend growth. Sustainability and ESGN/AEnvironmental ScoreN/A Percentage of Shares Shorted10.71% of the float of Autonomix Medical has been sold short.Short Interest Ratio / Days to CoverAutonomix Medical has a short interest ratio ("days to cover") of 0.3, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Autonomix Medical has recently increased by 126.22%, indicating that investor sentiment is decreasing significantly. News and Social Media2.5 / 5News Sentiment0.41 News SentimentAutonomix Medical has a news sentiment score of 0.41. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.70 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 4 news articles for Autonomix Medical this week, compared to 2 articles on an average week.Search InterestOnly 1 people have searched for AMIX on MarketBeat in the last 30 days. This is a decrease of -93% compared to the previous 30 days.MarketBeat Follows14 people have added Autonomix Medical to their MarketBeat watchlist in the last 30 days. This is an increase of 100% compared to the previous 30 days. Company Ownership1.7 / 5Insider TradingN/A Insider Buying vs. Insider SellingIn the past three months, Autonomix Medical insiders have not sold or bought any company stock.Percentage Held by Insiders32.40% of the stock of Autonomix Medical is held by insiders. A high percentage of insider ownership can be a sign of company health.Percentage Held by InstitutionsOnly 10.78% of the stock of Autonomix Medical is held by institutions.Read more about Autonomix Medical's insider trading history. Receive AMIX Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Autonomix Medical and its competitors with MarketBeat's FREE daily newsletter. Email Address AMIX Stock News HeadlinesAutonomix Medical Inc News (AMIX) - Investing.comAugust 24 at 6:56 AM | investing.comCritical Survey: Rapid Micro Biosystems (NASDAQ:RPID) & Autonomix Medical (NASDAQ:AMIX)August 24 at 4:01 AM | americanbankingnews.com“Sell Nvidia before earnings”Eric Fry just went live with one of his most controversial calls yet: “Sell Nvidia.” While Wall Street has been chasing the AI giant, Eric says its biggest customers are now its biggest competitors — and that could spell trouble ahead. Instead, he’s urging investors to consider a little-known hardware company that’s already starting to take off. In fact, while Nvidia has slipped over the past 30 days, this “off-the-radar” stock is up 18% — and Eric believes the run is just beginning. | InvestorPlace (Ad)Autonomix Medical, Inc. Granted New European Patent for First-in-Class Catheter-Based TechnologyAugust 20, 2025 | finance.yahoo.comAutonomix Medical, Inc. Expands Patent Portfolio with New European Patent to Enhance Medical Device Technology for Physiological MonitoringAugust 20, 2025 | quiverquant.comQAutonomix Medical, Inc. to Participate in Virtual Investor Webinar Hosted by Ladenburg Thalmann ...August 18, 2025 | gurufocus.comAutonomix Medical, Inc. to Participate in Virtual Investor Webinar Hosted by Ladenburg Thalmann ...August 18, 2025 | gurufocus.comAutonomix Medical, Inc. to Participate in Virtual Investor Webinar Hosted by Ladenburg Thalmann & Co. Inc.August 18, 2025 | globenewswire.comSee More Headlines AMIX Stock Analysis - Frequently Asked Questions How have AMIX shares performed this year? Autonomix Medical's stock was trading at $3.76 at the beginning of the year. Since then, AMIX stock has decreased by 72.9% and is now trading at $1.02. How were Autonomix Medical's earnings last quarter? Autonomix Medical, Inc. (NASDAQ:AMIX) issued its quarterly earnings data on Wednesday, August, 13th. The company reported ($1.07) earnings per share for the quarter, missing the consensus estimate of ($0.98) by $0.09. When did Autonomix Medical's stock split? Autonomix Medical shares reverse split on the morning of Friday, October 25th 2024.A 1-20 reverse split was announced. The number of shares owned by shareholders was adjusted after the market closes on Thursday, October 24th 2024. An investor that had 100 shares of stock prior to the reverse split would have 5 shares after the split. When did Autonomix Medical IPO? Autonomix Medical (AMIX) raised $11 million in an initial public offering (IPO) on the week of January 29th 2024. The company issued 2,234,222 shares at a price of $5.00 per share. How do I buy shares of Autonomix Medical? Shares of AMIX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of Autonomix Medical own? Based on aggregate information from My MarketBeat watchlists, some other companies that Autonomix Medical investors own include Advanced Micro Devices (AMD), Luminar Technologies (LAZR), New Found Gold (NFGC), Tesla (TSLA), Global X Artificial Intelligence & Technology ETF (AIQ), Aldeyra Therapeutics (ALDX) and Allegro MicroSystems (ALGM). Company Calendar Last Earnings8/13/2025Today8/26/2025Next Earnings (Estimated)11/14/2025Fiscal Year End3/31/2026Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry MED INSTRUMENTS Sub-IndustryMedical Equipment Current SymbolNASDAQ:AMIX Previous SymbolNASDAQ:AMIX CIK1617867 Webautonomix.com Phone713-588-6150FaxN/AEmployees1Year FoundedN/APrice Target and Rating Average Price Target for Autonomix Medical$16.50 High Price Target$28.00 Low Price Target$5.00 Potential Upside/Downside+1,517.6%Consensus RatingBuy Rating Score (0-4)3.00 Research Coverage2 Analysts Profitability EPS (Trailing Twelve Months)($5.74) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income-$11.41 million Net MarginsN/A Pretax MarginN/A Return on Equity-172.93% Return on Assets-133.39% Debt Debt-to-Equity RatioN/A Current Ratio4.57 Quick Ratio4.57 Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book Value$3.29 per share Price / Book0.31Miscellaneous Outstanding Shares5,146,000Free Float3,479,000Market Cap$5.25 million OptionableN/A Beta-2.96 10 Best Stocks to Own: Fall 2025Enter your email address and we'll send you MarketBeat's list of ten stocks that are set to soar in Fall 2025, despite the threat of tariffs and other economic uncertainty. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.Get This Free Report This page (NASDAQ:AMIX) was last updated on 8/26/2025 by MarketBeat.com Staff From Our PartnersBuffett’s $325 Billion Cash Problem — Solved by Gold?A bombshell announcement is just weeks away — and it could send shockwaves through the gold market. Most inves...Golden Portfolio | SponsoredTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | SponsoredFed Decision Warning: How to Protect Your Wealth Before September 17th On September 17th, the Fed faces an impossible choice—and Wall Street insiders are already preparing for the...American Alternative | SponsoredGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredBONUS GUIDE - Ben Stein Prepares For the Next Financial CrisisWith inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist ...Goldco Precious Metals | SponsoredNew Federal Land Rush About to Start?A $100 Trillion Wealth Shift Is Already Underway Lithium. Oil. Gold. Trillions in U.S. resources are being ...Stansberry Research | SponsoredTake a look at this picture ...A strange investment secret — discovered just a few short weeks before this image was taken — correctly predic...Weiss Ratings | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Autonomix Medical, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Autonomix Medical With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.